Curanex Pharmaceuticals Inc (CURX)
Nasdaq: CURX · Pharmaceutical Preparations · Jericho, NY · filing with the SEC since 2024
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 |
|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 |
| Report filed | Mar 30, 2026 | · |
| Research and development | 2,985,873 | · |
| General and administrative | 1,253,203 | 290,386 |
| Total operating expenses | 4,239,076 | 365,062 |
| Operating income | -4,239,076 | -365,062 |
| Interest expense | 8,537 | · |
| Net income | -4,225,106 | -361,506 |
| Earnings per share, basic | -0.17 | -0.03 |
| Earnings per share, diluted | -0.17 | -0.03 |
| Weighted average shares, basic | 25,497,328 | 13,259,016 |
| Weighted average shares, diluted | 25,497,328 | 13,259,016 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperatingNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding